Risk markers of incident atrial fibrillation in patients with coronary heart disease

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

(2019) Juhani Knuuti et al.   EUROPEAN HEART JOURNAL

Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study

(2019) Katrin Kemp Gudmundsdottir et al.   EUROPACE

Screening for atrial fibrillation: a call for evidence

(2019) Nicholas R Jones et al.   EUROPEAN HEART JOURNAL

Incidence of subclinical atrial fibrillation in a South Asian population

(2018) James O'Neill et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation

(2017) Emma Svennberg et al.   HEART

Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease

(2017) Santeri Nortamo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

(2017) Daniel Lindholm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

(2017) Claes Held et al.   Journal of the American Heart Association

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

(2016) Ziad Hijazi et al.   CLINICAL CHEMISTRY

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

(2016) Ziad Hijazi et al.   EUROPEAN HEART JOURNAL

Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram

(2016) Michelle L. Meyer et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

NT-proBNP is a powerful predictor for incident atrial fibrillation — Validation of a multimarker approach

(2016) Emma Svennberg et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study

(2016) Lars Wallentin et al.   LANCET

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

(2015) Rocío Carda et al.   CARDIOLOGY

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study

(2015) Andrew M. Tonkin et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

(2014) Lars Wallentin et al.   CIRCULATION

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies

(2014) Moritz F. Sinner et al.   EUROPACE

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

B‐type Natriuretic Peptides for the Prediction of Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study

(2014) Rakesh K. Mishra et al.   Journal of the American Heart Association

Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation

(2013) Michiel Rienstra et al.   AMERICAN HEART JOURNAL

Biomarkers in atrial fibrillation: a clinical review

(2013) Z. Hijazi et al.   EUROPEAN HEART JOURNAL

N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity

(2013) Kristen K Patton et al.   HEART

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

(2013) Alvaro Alonso et al.   Journal of the American Heart Association

Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation

(2012) Chern-En Chiang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

(2012) Stephan D. Fihn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

(2010) Harvey White et al.   AMERICAN HEART JOURNAL

Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community

(2010) Renate B. Schnabel et al.   CIRCULATION

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

(2009) Torbjørn Omland et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul Study

(2007) Gregory M. Marcus et al.   AMERICAN HEART JOURNAL